The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
Open accessAbstract
Abstract —Oxidation of low density lipoprotein (LDL) phospholipids containing arachidonic acid at the sn -2 position occurs when a critical concentration of “seeding molecules” derived from the lipoxygenase pathway is reached in LDL. When this critical concentration is reached, the nonenzymatic oxidation of LDL phospholipids produces a series of biologically active, oxidized phospholipids that mediate the cellular events seen in the developing fatty streak. Normal high density lipoprotein (HDL) contains at least 4 enzymes as well as apolipoproteins that can prevent the formation of the LDL-derived oxidized phospholipids or inactivate them after they are formed. In the sense that normal HDL can prevent the formation of or inactivate these inflammatory LDL-derived oxidized phospholipids, normal HDL is anti-inflammatory. HDL from mice that are genetically predisposed to diet-induced atherosclerosis became proinflammatory when the mice are fed an atherogenic diet, injected with LDL-derived oxidized phospholipids, or infected with influenza A virus. Mice that were genetically engineered to be hyperlipidemic on a chow diet and patients with coronary atherosclerosis, despite normal lipid levels, also had proinflammatory HDL. It is proposed that LDL-derived oxidized phospholipids and HDL may be part of a system of nonspecific innate immunity and that the detection of proinflammatory HDL may be a useful marker of susceptibility to atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Self-citationThe oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,224
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Self-citationCushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Self-citationMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Self-citationNapoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
Self-citationLipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
Self-citationWatson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Self-citationNavab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Self-citationNavab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Self-citationShaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Self-citationHörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationDisruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D., & Rosenblat, M. (2000) · Circulation · doi:10.1161/01.cir.101.21.2510 · Cited by 460
Chang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K.-H., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 459
Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., & La Du, B. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1617 · Cited by 458
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Self-citationShih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Self-citationWatson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Self-citationAtherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 360
Self-citationApolipoprotein-mediated removal of cellular cholesterol and phospholipids
Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 341
Prosthesis-Patient Mismatch Affects Survival After Aortic Valve Replacement
Rao, V., Jamieson, W. R. E., Ivanov, J., Armstrong, S., & David, T. E. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_3.iii-5 · Cited by 312
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119369 · Cited by 309
Self-citationLee, H., Shi, W., Tontonoz, P., Wang, S., Subbanagounder, G., Hedrick, C. C., Hama, S., Borromeo, C., Evans, R. M., Berliner, J. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.6.516 · Cited by 292
Self-citationSerum Paraoxonase After Myocardial Infarction
Ayub, A., Mackness, M. I., Arrol, S., Mackness, B., Patel, J., & Durrington, P. N. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.2.330 · Cited by 287
Inflammatory Markers of Coronary Risk
Rader, D. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431609 · Cited by 260
PLASMA LIPID TRANSFER PROTEINS, HIGH-DENSITY LIPOPROTEINS, AND REVERSE CHOLESTEROL TRANSPORT
Bruce, C., Chouinard, R. A., & Tall, A. R. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.297 · Cited by 258
Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., & Lusis, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118589 · Cited by 247
Self-citationLeitinger, N., Tyner, T. R., Oslund, L., Rizza, C., Subbanagounder, G., Lee, H., Shih, P. T., Mackman, N., Tigyi, G., Territo, M. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12010 · Cited by 242
Self-citationIndependent Prognostic Value of Elevated C-Reactive Protein in Unstable Angina
Ferreirós, E. R., Boissonnet, C. P., Pizarro, R., Merletti, P. F. G., Corrado, G., Cagide, A., & Bazzino, O. O. (1999) · Circulation · doi:10.1161/01.cir.100.19.1958 · Cited by 222
Subbanagounder, G., Leitinger, N., Schwenke, D. C., Wong, J. W., Lee, H., Rizza, C., Watson, A. D., Faull, K. F., Fogelman, A. M., & Berliner, J. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2248 · Cited by 216
Self-citationJames, R. W., Leviev, I., & Righetti, A. (2000) · Circulation · doi:10.1161/01.cir.101.19.2252 · Cited by 215
Infection and Inflammation Induce LDL Oxidation In Vivo
Memon, R. A., Staprans, I., Noor, M., Holleran, W. M., Uchida, Y., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1536 · Cited by 207
Watson, A. D., Subbanagounder, G., Welsbie, D. S., Faull, K. F., Navab, M., Jung, M. E., Fogelman, A. M., & Berliner, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24787 · Cited by 206
Self-citationParaoxonase and coronary heart disease
Mackness, M. I., Mackness, B., Durrington, P. N., Fogelman, A. M., Berliner, J., Lusis, A. J., Navab, M., Shih, D., & Fonarow, G. C. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199808000-00006 · Cited by 204
Self-citationRole of inflammation in coronary plaque disruption.
Buja, L. M., & Willerson, J. T. (1994) · Circulation · doi:10.1161/01.cir.89.1.503 · Cited by 193
Castellani, L. W., Navab, M., Van Lenten, B. J., Hedrick, C. C., Hama, S. Y., Goto, A. M., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119554 · Cited by 184
Self-citationApolipoprotein J Is Associated with Paraoxonase in Human Plasma
Kelso, G. J., Stuart, W. D., Richter, R. J., Furlong, C. E., Jordan-Starck, T. C., & Harmony, J. A. K. (1994) · Biochemistry · doi:10.1021/bi00169a026 · Cited by 179
Thomas, C. E., & Jackson, R. L. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23163-9 · Cited by 176
Shi, W., Haberland, M. E., Jien, M.-L., Shih, D. M., & Lusis, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.1.75 · Cited by 174
Self-citationLDL- is a lipid hydroperoxide-enriched circulating lipoprotein
Sevanian, A., Bittolo-Bon, G., Cazzolato, G., Hodis, H., Hwang, J., Zamburlini, A., Maiorino, M., & Ursini, F. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37250-3 · Cited by 171
Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J.-H., Huber, J., Faull, K. F., Grass, D., Navab, M., Fogelman, A. M., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1291 · Cited by 154
Self-citationShih, P. T., Elices, M. J., Fang, Z. T., Ugarova, T. P., Strahl, D., Territo, M., Frank, J. S., Kovach, N. L., Cabañas, C., Berliner, J. A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5710 · Cited by 149
Self-citationShi, W., Wang, N. J., Shih, D. M., Sun, V. Z., Wang, X., & Lusis, A. J. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1078 · Cited by 139
Self-citationLenten, B. J. V., Wagner, A. C., Navab, M., & Fogelman, A. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004074200 · Cited by 134
Self-citationInduction of P-Selectin by Oxidized Lipoproteins
Vora, D. K., Fang, Z.-T., Liva, S. M., Tyner, T. R., Parhami, F., Watson, A. D., Drake, T. A., Territo, M., & Berliner, J. A. (1997) · Circulation Research · doi:10.1161/01.res.80.6.810 · Cited by 128
Self-citationForte, T. M., Bielicki, J. K., Goth–Goldstein, R., et al. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39763-7 · Cited by 123
Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke
Polidori, M. C., Frei, B. B., Cherubini, A., Nelles, G., Rordorf, G. A., Keaney, J. F., Schwamm, L. H., Mecocci, P., Koroshetz, W. J., & Beal, M. F. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00085-9 · Cited by 119
Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium.
Schwartz, D. A., Andalibi, A., Chaverri-Almada, L., Berliner, J. A., Kirchgessner, T. G., Fang, Z. T., Tekamp-Olson, P., Lusis, A. J., Gallegos, C., & Fogelman, A. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117548 · Cited by 115
Self-citationNovel Function of Lecithin-Cholesterol Acyltransferase
Goyal, J., Wang, K., Liu, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16231 · Cited by 114
Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities
Subbanagounder, G., Watson, A. D., & Berliner, J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00233-1 · Cited by 100
Self-citationThomas, J. P., Kalyanaraman, B., & Girotti, A. W. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1496 · Cited by 99
Antioxidants and atherosclerosis: A current assessment
Chisolm, G. M. (1991) · Clinical Cardiology · doi:10.1002/clc.4960141304 · Cited by 99
Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
Phillips, M. C., Gillotte, K. L., Haynes, M. P., Johnson, W. J., Lund‐Katz, S., & Rothblat, G. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00312-2 · Cited by 98
Vohl, M., Neville, T. A.-M., Kumarathasan, R., Braschi, S., & Sparks, D. L. (1999) · Biochemistry · doi:10.1021/bi982258w · Cited by 92
Circulating Markers of Inflammation for Vascular Risk Prediction: Are they Ready for Prime Time
Shah, P. K. (2000) · Circulation · doi:10.1161/01.cir.101.15.1758 · Cited by 92
Stafforini, D. M., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (1992) · PubMed · Cited by 90
Hedrick, C. C., Hassan, K., Hough, G. P., Yoo, J., Simzar, S., Quinto, C. R., Kim, S.-M., Dooley, A. N., Langi, S., Hama, S. Y., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1946 · Cited by 89
Self-citationModified Lipoproteins in the Pathogenesis of Atherosclerosis
Parthasarathy, S. (1994) · Cited by 74
Chen, N., Liu, Y., Greiner, C. D., & Holtzman, J. L. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.107692 · Cited by 70
Induction of Monocyte Binding to Endothelial Cells by MM-LDL: Role of Lipoxygenase Metabolites
Honda, H. M., Leitinger, N., Frankel, M. B., Goldhaber, J. I., Natarajan, R. D., Nadler, J. L., Weiss, J. N., & Berliner, J. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.680 · Cited by 68
Self-citationSubramanian, V. S., Goyal, J., Miwa, M., Sugatami, J., Akiyama, M., Liu, M., & Subbaiah, P. V. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00072-4 · Cited by 63
Genetic Differences in Endothelial Cells May Determine Atherosclerosis Susceptibility
Breslow, J. L. (2000) · Circulation · doi:10.1161/01.cir.102.1.5 · Cited by 60
Immune recognition of OxLDL in atherosclerosis
Kearney, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10426 · Cited by 51
Stress‐induced changes in blood pressure and left ventricular function in mild hypertension
Lindvall, K., Kahan, T., De, U., Östergren, J., & Hjemdahl, P. (1991) · Clinical Cardiology · doi:10.1002/clc.4960140208 · Cited by 45
Itabe, H., Hosoya, R., Karasawa, K., Jimi, S., Saku, K., Takebayashi, S., Imanaka, T., & Takano, T. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022416 · Cited by 39
Liu, M., Clair, R. W. S., & Subbaiah, P. V. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33886-4 · Cited by 10
Preparation of lipid hydroperoxide-free low-density lipoproteins
Shwaery, G. T., MOWRI, H.-O., Keaney, J. F., & Frei, B. B. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00108-1 · Cited by 9
Cited by
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Self-citationZheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Self-citationKontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 630
Metadata
- Authors
- Navab, M., Berliner, J. A., Subbanagounder, G., Hama, S., Lusis, A. J., Castellani, L. W., Reddy, S., Shih, D., Shi, W., Watson, A. D., Van Lenten, B. J., Vora, D., & Fogelman, A. M.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-04
- Volume
- 21
- Issue
- 4
- Pages
- 481-488
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2122896036
- Cited by
- 442
- References
- 82
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.